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In this study, we reported the cloning and over expression of a gene coding for human collagen peptide 
(CP6) in Escherichia coli and investigated the protective effects of CP6 on UVA-irradiated human skin 
fibroblasts cells. The collagen peptide (CP6) was highly soluble and the expression level was 
approximately 10% of the total bacteria proteins. Also, we performed assays with 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT), Annexin V-fluorescein isothiocyanate/propidine iodide 
(Annexin V-FITC/PI) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) 
methods to investigate the cytoprotective effects of CP6 on the proliferation of UVA-damaged human 
skin fibroblasts cells. Radiation dosages (5 J/cm
2
) significantly decreased the proliferation activities of 
human skin fibroblasts cells (HSF). Compared with UVA irradiated group, in the given concentration, 
CP6 could improve the activities of cell’s proliferation (P<0.05) and decrease the apoptosis rate of cell 
significantly (P<0.01). UVA could damage the human skin fibroblasts cell in vitro. The CP6 had 
protective effects on HSF irradiated by UVA, and the mechanism of this effect might be associated with 
its anti-oxidative effect and enhancing cell’s proliferation. 
 





UV radiation forms a part of the electromagnetic 
spectrum with wavelengths between 100 and 400 nm. It 
is divided into three categories depending on the 
wavelength, long wave UVA (315-400 nm), medium wave 
UVB (280 to 315 nm), and short wave UVC (100 to 280 
nm) (Svobodováet al., 2003). The UV light that reaches 
the earth’s surface comprises primarily UVA wavelengths 
and the remainder (approximately 5%) contains the (295-
320 nm) UVB radiation (VanderLeun, 2004; Pattison and 
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absorbed in the ozone layer, comprises more than 95% 
of the UV light that reaches the earth. UVA penetrates the 
epidermis and affects both epidermal and dermal layers 
of the skin (Lyons and O'Brien, 2002; Mortensen et al., 
2008). At a cellular level, UVA-induced damage occurs 
mainly indirectly via oxidative processes initiated by 
endogenous photosensitization. UVA exposure causes 
significant oxidative stress via generation of reactive 
oxygen species (ROS) such as singlet oxygen, hydroxyl 
radical, superoxide anion and hydrogen peroxide as well 
as reactive nitrogen species (RNS), mostly nitric oxide 
and nitric dioxide (Svobodová et al., 2007). Both UVA and 
UVB cause wavelength-dependent damage to human 
skin including skin cancer, whose incidence is drama-
tically increasing (Pinnel, 2003). UVA penetrates through 
epidermis deep into the dermis. UVA-induced responses 
in cells happen mainly because of oxidative processes 
initiated by endogenous photosensitization. UVA can not 
only affect numerous signal transduction pathways and   
impair  the  immune  system  but  also  indirectly  produce 




structural damage to the DNA (8-oxoguanine is the most 
common lesion) and inhibit DNA repair (Svobodova et al., 
2006). Apropos the skin photoprotection, to date most of 
studies have involved UVB protection. Little research has 
involved prevention against UVA skin damage 
(Svobodová et al., 2007). 
The generation of recombinant proteins is one of the 
most widely-used techniques in biotechnology research 
(Makrides, 1996). E. coli is one of the most popular hosts 
for producing recombinant proteins. In addition to its 
simplicity, safety, and known genetic properties, a major 
asset is the fact that transformation of E. coli with foreign 
DNA is easy with well-established genetic manipulation 
methods. So generation of stable cell lines is a speedy 
process. The major advantage of E. coli, however, is its 
ability to produce proteins in large quantities and to grow 
very quickly compared with mammalian cells, which 
enables excellent space/time yields (Swartz, 2001; 
Baneyx, 1999; Leonhartsberger, 2006). Collagen alpha-
2(VI) acts as a cell-binding protein that is involved in the 
organization of the extracellular matrix (Freise et al., 
2009). The collagen extracted from animal bones, hide, 
and fish scales is called gelatin. The hydrolysate com-
ponent of collagen is called collagen peptide (CP), and it 
is used as a dietary supplement. Collagen peptide 
ingestion may show therapeutic effects on bones, 
tendons, and skins (Lampe and Bushby, 2005; Merlini et 
al., 2008; Tanaka et al., 2009). In this study, we described 
the cloning and expression of the collagen peptide 
COL6A (or CP6) in E. coli and defined a purification 
protocol. Since the effects of PC6 in the treatment of UVA 
caused damage have not been reported yet, in this study, 
we investigated the potential ability of CP6 to ameliorate 
UVA-induced damage in HSF. The procedure for expres-
sion and purification of target protein was produced, 




MATERIALS AND METHODS 
 
DMEM, penicillin and streptomycin were purchased from GIBCO-
BRL (NY, USA). The restriction enzymes EcoRI and SalI, T4 DNA 
ligase and Ex Taq were purchased from Sigma Chemical Co. (MO, 
USA). The DNA gel extraction, plasmid extraction and polymerase 
chain reaction (PCR) product purification kits were purchased from 
Takara Co. (DaLian, China). CP6 (purity > 96%) was purified and 




Expression plasmid construction and expression of collagen 
peptide (CP6)  
 
For constructing a plasmid containing the Homo sapiens VI 
collagen peptide gene, following oligonucleotides were used for 
PCR amplification: F,R. (F:5′-CCGGAATTCGGCAACAAAGGA 
GCCAAG-3′and :5′-GCGTCGACGTTCTTGACAGCCTCCTT-3′). 
After incubation at 94°C for 5 min, 30 repeated cycles of thermal 
denaturation at 94°C for 30 s, annealing at 55°C for 30 s, and  





by a single step of incubation at 72°C for 7 min. PCR products were 
analyzed on 1.2% agarose gel, and the desired band was excised 
from the gel and purified using DNA extraction kit. Then it digested 
with EcoRI and SalI and ligated into pET32a vector using T4 DNA 
ligase. The recombinant plasmid containing H. sapiens collagen 
peptide gene was introduced into Escherichia coli DE3. DE3 cells 
were grown in LB medium supplemented with ampicillin, when the 
OD at 600 nm showed a reading of 0.6-0.7, protein expression was 
induced by the addition of isopropyl-β-D-thiogalactoside (IPTG) 
(final concentration, 1 mmol/L), and growth was continued for 7 h at 
28°C. The cells were collected by centrifugation at 12000 g at 4°C, 
after the cells were broken by brief pulses of sonication on ice. The 
supernatant and the precipitate were collected as soluble and 




Cell culture  
 
HSF were grown in DMEM supplemented with streptomycin (100 
U/mL), penicillin (0.1 mg/mL) and glutamine (4 mmol/L) in a 
humidified atmosphere with 5% (v/v) CO2 at 37°C. The cells were 
subcultured following trypsinization (Krischel et al., 1998). For all 





 and grown near to confluence. 
 
 
Cytotoxicity of CP6  
 
Culture medium was removed and cells were treated with serum-
free medium containing CP6 (0.1-14 mg/L) at 37°C for 24 h. Control 
cells were treated with serum-free medium containing DMSO 
(0.5%, v/v) at the same conditions. Cell viability was evaluated 
using the MTT assay.  
 
 
UVA irradiation and treatment  
 
For irradiation, a battery of UVA lamps (Phillips) served as the UVA 
source. The irradiation intensity was measured using a UVA 
radiometer (Solar Light, China). For all experiments, HSF cells were 
irradiated with the UVA dose of 5 J/cm
2
. When grown to 80 to 90% 
confluence, cells were subjected to irradiation with both UVA lamps 
(320-400 nm) (PHILIPS) at a dose of 5 J/cm
2
 (Merwald et al., 
2005), which were monitored by UVA radiometers (Solar Light, 
China) respectively. 
Cells undergone different treatments: (A) When cells were 
cultured to 80% confluence, cells were incubated with various 
doses of CP6 for 24 h. (B) When cells were cultured to 80% 
confluence, various doses of CP6 (2, 4, 6, 8, 10 mg/mL) were 
added into the culture, and then cells were exposed to UVA (5 
mJ/cm
2
). (C) When cells were cultured to 80% confluence, cells 
were irradiated with UVA (5 mJ/cm
2
). And then the cells were 
cultured with various doses of CP6 (2, 4, 6, 8, 10 mg/mL) for 12 h. 
During irradiation, medium was discarded and cells were covered 
with 2 mL of PBS. At last, we selected the surface of the sun reach 
the earth close to UVA (5 J/cm
2
) as the source of irradiation. 
 
 
MTT assay  
 
Tetrazolium salt, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT), is reduced by intracellular dehydrogenases of 
viable living cells that leads to formation of purple formazan 
crystals, insoluble in aqueous solutions. After dissolution in organic 
solvent, the absorbance is monitored. Serum-free medium 
supplemented  with MTT (5 mg/mL) was applied  to the cells for 2 h  






Figure 1. Schematic diagrams of pET-32a (+) expression vector. The recombinant gene encoding Homo sapiens VI collagen 




(37°C). The medium was removed and the crystals were dissolved 




Flow cytometric analyses of apoptotic and necrotic cells  
 
The treated or control cells were harvested by trypsinization and 
collected by centrifugation at 300×g for 5 min at room temperature. 
Cells were washed with cold PBS and stained with Annexin V/PI 
detection kit (Abcam) according to the manufacturer’s instructions. 
After removing most of the PBS, the cell pellet was resuspended in 
400 µL of 1× binding buffer with 5 µL of Annexin V-FITC mixture and 
gently vortexed. Propidium iodide (10 µL) was then added, and the 
cells were incubated for 5 min. Data were analyzed using the 
WinMDI software package. 
 
 
TUNEL assay  
 
DNA-fragmentation in HSF cells was evaluated by terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) 
assay (Shen et al., 2001; Itoh and Horio, 2001). After UVA-
irradiation and then incubation, the apoptosis of cell samples was 
measured by TUNEL staining according to the manufacturer’s 
protocol of TUNEL assay (Roche Diagnostics, Shanghai, China). 
Briefly, tissue sections on slides were dewaxed and rehydrated by 
standard protocols (example, by heating at 60°C followed by 
washing in xylene and rehydration through a graded series of 
ethanol and double distilled water) (Gavrieli et al., 1992; Portera-
Cailliau et al., 1994; Cortés-Gutiérrez et al., 2007), and incubated 
for 15 to 30 min at 21 to 37°C with Proteinase K working solution. 
Following two rinses with PBS, 50 L of the TUNEL reaction mixture 
was added and samples were incubated for 60 min at 37°C in a 
humidified atmosphere in the dark. Slides were then rinsed three 
times with PBS and analyzed in a drop of PBS under a 
fluorescence microscope. An excitation wavelength in the range of 




Statistical analysis  
 
Results were expressed as the mean ± S.D. All statistical analyses 
were performed using SPSS v16.0 statistical analysis software. A 





Expression plasmid construction and expression of 
CP6 
 
The nucleotide sequence of Homo sapiens COL6A2, 
collagen, type VI, alpha 2 (684bp) was determined and 
submitted to GenBank under accession CR536573.1. In 
order to construct expression plasmids, PCR was perfor-
med with genomic full-length human COL6A2 collagen, 
typeVI, alpha2 [Homo sapiens] purchased from Origene 
technologies (USA) as a template and primers. The 
forward primer contained an EcoRI restriction site, while 
the reverse primer contained a SalI site. The amplified 
fragment were digested with EcoRI and SalI and inserted 
into the EcoRI and SalI sites of pET expression vector, 
followed by ligation. The plasmids were transferred into 
E. coli DH5a and were then introduced into E. coli BL21 
(DE3) and expressed under the control of T7 promoter.  
The expressed collagen peptide (CP6) was about 46 kDa  






Figure 2. Expression plasmid construction and expression of CP6. (a) The PCR products of target genes. M, DNA marker; lane 1, the PCR fragment of CP6. (b) Restriction analysis of 
recombinant plasmid pET-32a-CP6. LaneM, DL2000 DNA marker; lane1, plasmid pET-32a-CP6 digested with EcoRI and SalI. Lane 2, the PCR fragment of CP6. (c) Expression of CP6 in E. 
coli BL21(DE3). Lane M: protein markers; Lane 1: un-induced E. coli cell lysate; Lane 2: E. coli lysate after IPTG induction; Lane 3: supernatant of the E. coli lysate after ultrasonication of the 
induced E. coli; Lane 4: pellet fraction of the E. coli lysate after ultrasonication of the induced E. coli. (d) Western blotting analysis of the E. coli lysate with commercial mouse anti-human 
collagen VI A2 antibody. Lane 1: un-induced E. coli cell lysate; Lane 2: pellet of the E. coli lysate after ultrasonication of the induced E. coli; Lane 3: supernatant of the E. coli lysate after 




and the expression level was approximately 10% 
of the total bacteria proteins. SDS-PAGE (Figure 
2) analysis revealed that most target proteins 
existed in soluble fractions. The majority of the 
expressed recombinant proteins were found to be 
soluble in the supernatant. Few proteins were 
found in the soluble fraction. This indicated that 
the target proteins (CP6) were mainly expressed 
in the soluble form E. coli. 
Effects of CP6 on cell viability in UVA-
irradiated cells 
 
The effects of CP6 at various doses on HSF cells 
viability were tested with MTT assay. The results 
showed that CP6 ranging from 2 to 12 mg/mL had 
no significant effects on cell viability (data not 
shown). None of the concentrations tested 
showed toxicity for the cells. Therefore, we chose 
2 and 10 mg/mL for all the experiments. 
The effects of CP6 on the viability of UV-
irradiated skin cells were assessed. HSF cells 
were pretreated with the The effects of CP6 on the 
viability of UV- irradiated skin cells were 
assessed. HSF cells were pretreated with the CP6 
at different final concentrations (2, 4, 6, 8, 10 
mg/mL) for 2 h respectively, and then were 
irradiated with UVA. Cell viability was evaluated 




Table 1. Effect of CP6 on UVA-induced HSF cells with the MTT (N=6,*P < 0.01). 
 
Parameter CP6 added before UVA-irradiation CP6 added after UVA-irradiation 
A Untreated control HSF cells 0.81267 ± 0.009352 0.8189 ± 0.00922 
B UVA-treated cells without CP6 0.4385 ± 0.032017 0.4125 ± 0.012017 
C UVA+2 mg/mL CP6 0.5065 ± 0.004324 0.4323 ± 0.006364 
D UVA+4 mg/mL CP6 0.5545 ± 0.013248* 0.453 ± 0.003288 
E UVA+6 mg/mL CP6 0.57333 ± 0.013186* 0.502 ± 0.015256* 
F UVA+8 mg/mL CP6 0.65483 ± 0.019874* 0.511 ± 0.02084* 




by the MTT colorimetric assay. As shown in Table 1, UVA-
irradiation reduced HSF cell viabilities to approximately 
53% of the control vaules. The survival rate of the cell 
pretreated with CP6 increased in a dose-dependent 
manner, and reached maximum value at the concen-
tration of 10 mg/mL. 
HSF cells were post-treated with the CP6 at different 
final concentrations (2, 4, 6, 8, 10 mg/mL) for 8 h respec-
tively. Cell viability was evaluated by the MTT colorimetric 
assay. As shown in Tablen 1, the survival rates of the cell 
post-treated with CP6 increased in a dose-dependent 
and time-dependent manner.  
Moreover, CP6 displayed significantly higher protection 
effects than therapeutic effects at their maximum efficient 
concentration of 10 mg/mL. In other words, the CP6 has 
better preventive effects than its therapeutic effects, so 
we will perform assays with Annexin V-FITC/PI and 
TUNEL to investigate the cytoprotective effects of CP6 on 




Effects of CP6 on UVA-induced apoptosis 
 
By the AnnexinV-PI method, cells were both Annexin V- 
and PI- indicating viability. Since dead cells are PI+, 
those Annexin V+ but PI- cells are apoptotic. As shown in 
Figure 3, UVA-irradiation induced a distinct apoptosis 
rate, which represents the population of apoptotic cells. 
Statistical analysis showed the apoptotic and dead 
proportions of the cell pretreated with CP6 decrease in a 
dose-dependent manner. CP6 administration (10 mg/mL) 
before UVA-irradiation could significantly decrease the 
apoptotic and dead proportion of HSF cells by 5.67%. 
CP6 itself did not cause DNA damage at used 
concentrations (data not shown). In UVA-exposed cells 
treated with CP6 a powerful ability to attenuate apoptosis 
appearance was evident (Figure 3). In UVA-irradiated 
cells (5 J/cm
2
) treated with CP6 before UVA-irradiation, 
an evident diminution of cell apoptosis was observed at 
all concentrations tested. The reduction was more 
apparent at a concentration of 10 mg/mL. CP6 was more 
potent in alleviation of UV-induced apoptosis at used 
concentrations. CP6 protection was dose-dependent and 
was the most efficient at the highest concentration tested.  
 
 
Effects of CP6 on the DNA-fragmentation in HSF cells 
 
The TUNEL method is a simple and sensitive method for 
the detection of apoptotic cells. Cells in early stages of 
apoptosis up to the stage when the morphological 
changes occur that are typical for apoptosis, including 
apoptotic bodies, are stained. Every slice selected 
needed five horizons, each horizon counting 500 cells, 
and stained positive cells were counted (%). Then the 
average was calculated. The ImageJ image analysis 
software processing, the results showed the apoptosis 
rate (%): A (Untreated control HSF cells) 6.28 ± 3.9352, B 
(UVA-treated cells without CP6) 40.21 ± 3.4043, C (UVA 
+ 2 mg/mL CP6) 25.89 ± 6.8796, D (UVA + 4 mg/mL 
CP6) 17.98± 4.2435*, E (UVA+6 mg/mL CP6) 10.23 ± 
1.4376*, F (UVA + 8 mg/mL CP6) 8.47± 1.6548*, G (UVA 
+ 8 mg/mL CP6) 7.98 ± 5.5488* (*P<0.05，n=6). As 
shown in Figure 4, CP6 administration (10 mg/mL) before 
UVA-irradiation led to fewer breaking of DNA than that of 
UVA model group as indicated by the significantly 
decreased number of labelled cells. The results 
suggested that CP6 can effectively suppress the 





Human skin is constantly exposed to the UV irradiation in 
sunlight. This can induce a number of pathobiological 
cellular changes. The development of novel preventive 
and therapeutic strategies depends on the molecular 
mechanisms of UV toxicity. A recent study indicates that 
UVA may play a pivotal role in human skin carcinogenesis 
(Agar et al., 2004). At present, protection against solar 
UVA-induced oxidative damage is mainly depends on 
using sunscreens. However, the current sunscreens 
formulations possess rather protection against UVB 
rather than UVA (Haywood et al., 2003). 
In this study, the cloning of a synthetic gene coding for 
CP6 was employed to induce function expression in E. 
coli.   The   expressed  CP6  was  about  46 kDa  and  the  










Figure 3. The results of HSF apoptosis by Annexin V/PI with flow cytometry. (a) Untreated control HSF cells. (b) Before adding CP6, UVA-treated cells showed apoptotic features. (c) CP6 (2 
mg/mL) added before UVA-irradiation. (d) CP6 (4 mg/mL) added before UVA-irradiation. (e) CP6 (6 mg/mL) added before UVA-irradiation. (f) CP6 (8 mg/mL) added before UVA-irradiation. 




expression level was approximately 10% of the 
total bacteria protein. Fractionation using SDS-
PAGE revealed that most CP6 existed in the 
soluble fraction (supernatant). 
It is well known that UVA is able to induce 
keratinocyte apoptosis, so we established a model 
for UVA-damage. Detection of cell death in the 
presence of CP6 demonstrated a dose-dependent 
cytoprotective effect as revealed by MTT, while 
CP6 did not increase cell death in control cultures, 
indicating that CP6 pre-treatment was safe and 
protective.  
To further investigate the cytoprotective effect of 
CP6, we have measured programmed cell death 
using Annexin V-FITC/PI and TUNEL methods 
Annexin V-FITC is a phospholipid-binding protein 
with a high affinity for phosphatidylserine (PS), 
which can be used as a sensitive probe for PS 
exposure to the cell membrane (Martin et al., 
1995; Bartkowiak et al., 1999). Double staining of 
the infected HSF with annexin V-FITC and PI in 
this research could distinguish apoptotic cells from 
necrotic cells (Yao et al., 2007; Chen et al., 2008). 
Cell death by apoptosis is characterized by DNA 
fragmentation in 200 to 250 and/or 30 to 50 
kilobases. 
Further, internucleosomal DNA fragmentation in 
180 to 200 base pairs may also occur. Such 
characteristics have been used to distinguish 
apoptotic cells  from  normal  or  necrotic  cells. To  






Figure 4. HSF apoptosis detected with TUNEL. (a) Untreated control HSF cells. (b) Before adding CP6, UVA-treated cells 
showed apoptotic features. (c) CP6 (2 mg/mL) added before UVA-irradiation. (d) CP6 (4 mg/mL) added before UVA-irradiation. 





detect apoptotic cells, whatever the pattern of DNA 
fragmentation, the TUNEL method is commonly utilized 
(Steensma et al., 2003; Huerta et al., 2007; Gautschi et 
al., 2009). In this study, the results suggested that CP6 
can effectively suppress the apoptosis induced by UVA-
irradiation. 
Although, we have confirmed that CP6 has powerful 
antioxidant and protective activities against UV-induced 
damage abilities in vitro, its overall effectiveness in skin 
protection in vivo have yet to be elucidated. Studies 
focused on the development of novel agents with 
protective activities against UV-induced damage, parti-
cularly from recombinant proteins techniques in 
biotechnology research are intensively being carried out. 
In this study, we concentrated on the UVA part of UV 






CP6 could improve the activities of proliferation and 
decrease the apoptosis rate of HSF. However, skin is a 
complicated organ consisting of several layers and types 
of cells which influence each other during and after 
irradiation. Thus, further research is needed to specify the 
effect of CP6 on other skin cells, as well as to define 
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